Abiopharma

Clinical trial NCT04312269: enrollment: not set → 70 participants.

Clinical trial NCT07609225: enrollment: not set → 15 participants.

Clinical trial NCT03433183: enrollment: not set → 21 participants.

Capital market presentation - first quarter of 2026

Signing on the sector series in the public transportation field by a subsidiary (51%)

Dormant shares – creation of dormant shares

Other Report or Announcement

The company’s liability balance as of 31.3.26, by maturity dates

Dividend in the amount of 439.60771 agorot per share, record date: 4.6.26, payment 11.6.26

Q1 report for 2026